Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tot'héma is an oral iron supplement formulated as a solution in ampoules, primarily indicated for the treatment of iron deficiency anemia and the prevention of iron deficiency during pregnancy. The formulation is a combination of ferrous gluconate, manganese gluconate, and copper gluconate. The addition of manganese and copper is intended to optimize iron absorption and utilization in the synthesis of hemoglobin. Developed by the French company Innothera, Tot'héma is designed to provide a highly bioavailable form of iron with improved gastrointestinal tolerance compared to some other oral iron salts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous gluconate + manganese gluconate + copper gluconate.